Research Market strategy
By Swissquote Analysts
Morning News

Fed Raises Rate by 0.5 Percentage Point, Signals More Increases Likely

The Federal Reserve approved an interest-rate increase of 0.5 percentage but also signalled rates may have to move even higher than previously thought to rein in inflation. Investors had widely anticipated the Fed would announce it would raise its key policy rate by half a percentage point. What they weren’t as sure of ahead of Wednesday’s meeting was how much higher Fed officials see interest rates having to go next year. Those who had been hoping the Fed might be done raising rates relatively soon may have been left disappointed. Fed officials signaled they see interest rates rising to around 5.1% by the end of next year, up from previous estimates in September of around 4.6%. Officials also said they see unemployment rising and economic growth being tepid in 2023.

By
Nadine PEREIRA
Morning News

U.S. Inflation Eased in November, CPI Report Shows

Consumer prices rose last month at the slowest 12-month pace since December 2021, closing out a year in which inflation hit the highest level in four decades and challenged the Federal Reserve’s ability to keep the U.S. economy on track. The Labor Department said that its consumer-price index, a measurement of what consumers pay for goods and services, climbed 7.1% in November from a year ago, down sharply from 7.7% in October. The pace built on a trend of moderating price increases since June’s 9.1% peak, but it remained well above the 2.1% average rate in the three years before the pandemic.

By
Nadine PEREIRA
Morning News

Amgen Agrees to Acquire Horizon Therapeutics for $27.8 Billion

Amgen Inc. agreed to acquire Horizon Therapeutics PLC for $27.8 billion, marking the largest healthcare merger of the year. Under the terms of the deal, Amgen will pay $116.50 for each Horizon share, a premium of 19.7% over the stock’s closing price Friday at $97.29 and nearly 50% over where it traded when the company said last month that it might be sold. While the shares of Horizon Therapeutics added 15.5%, Amgen edged 0.7% lower.

By
Nadine PEREIRA
Morning News

Ericsson Reaches Deal to End Patent-related Legal Disputes With Apple

Swedish telecom equipment group Ericsson announced that it has reached a multi-year, global patent license agreement with Apple Inc. (-0.3%), ending all ongoing patent-related legal disputes in several countries. The agreement includes a cross-license relating to patented cellular standard-essential technologies and grants certain other patent rights.

By
Mathieu VILLARD
Morning News

Credit Suisse Completes $2.4 Billion Capital Raise as It Advances Cost Cuts

Credit Suisse Group AG said Thursday that it completed its latest rights offering and had put into action around 80% of the cost cuts it planned for 2023, as the bank maintains course through its painful strategic review. The Swiss lender said that 98.2% of rights offered had been exercised, or around 873 million new shares, until the end of the rights period at midday Zurich time on Thursday. The gross proceeds of the rights offering amount to approximately CHF2.24 billion ($2.38 billion), which, added to a previous capital increase, should raise around CHF4.0 billion, the company said.

By
Nadine PEREIRA
Morning News

GSK, Sanofi Shares Jump After U.S. Judge Dismisses Zantac Lawsuit

Shares in pharmaceutical companies GSK PLC and Sanofi SA traded higher after a U.S. judge dismissed a series of lawsuits around a heartburn treatment that the companies had marketed. The lawsuits, which numbered in the tens of thousands, alleged that the drug, called Zantac, could cause cancer. The judge concluded on Tuesday that there was no scientific evidence to support the claim that Zantac’s active substance, called ranitidine, was carcinogenic. Shares in GSK were trading 7.5% higher on Wednesday, while Sanofi stock was up 6.1%.

By
Nadine PEREIRA
Morning News

Airbus Warns It Will Miss Full-Year Delivery Target

Airbus SE, the world’s biggest plane maker, said it would likely miss its key delivery target this year after the company’s chief executive warned that supply-chain woes were still at least six months away from normalizing. The European manufacturer said on Tuesday that due to a “complex operating environment,” Airbus’s previously forecast goal of achieving around 700 deliveries this year is now “out of reach.” Such a miss is rare in the commercial jet-making business, where annual deliveries offer bragging rights between Airbus and rival Boeing Co. but also go directly into cash flow: Much of a plane’s cost is only paid for after delivery.

By
Nadine PEREIRA
Morning News

Credit Suisse’s Investment Bank Spinoff Attracts Saudi Crown Prince

Saudi Arabia’s crown prince and a U.S. private-equity firm run by Barclays PLC’s former chief executive are among investors preparing to invest $1 billion or more into Credit Suisse’s new investment bank, people familiar with the matter said. Crown Prince Mohammed bin Salman is considering an investment of around $500 million to back the new unit, CS First Boston, and its CEO-designate, Michael Klein, some of the people said. Additional financial backing could come from U.S. investors including veteran banker Bob Diamond ‘s Atlas Merchant Capital, people familiar with that potential investment said.

By
Mathieu VILLARD
Morning News

United Airlines Close to Deal for Dozens of Boeing 787 Dreamliners

United Airlines Holdings Inc. is close to a deal to order dozens of Boeing Co. 787 Dreamliners, people familiar with the matter said. An agreement between the Chicago-based carrier and Boeing could be completed as soon as this month, some of these people said. If completed, the deal would be worth billions of dollars in revenue and mark a victory for the U.S. plane maker over its European rival Airbus SE, which had competed for the deal, people familiar with the matter said. Boeing has resumed deliveries of the Dreamliner after a nearly two-year freeze following a string of manufacturing and regulatory issues.

By
Nadine PEREIRA
Morning News

Swiss Inflation Steady At 3.0%

Switzerland's consumer price inflation remained unchanged in November, data from the Federal Statistical Office showed. Consumer prices rose 3.0 percent year-on-year in November, the same as seen in October. This was in line with economists' expectations. On a monthly basis, consumer prices remained stable in November, after a 0.1 percent rise in the previous month. Economists expected prices to remain unchanged.

By
Mathieu VILLARD